Atara Biotherapeutics
ATRA
ATRA
120 hedge funds and large institutions have $1.94B invested in Atara Biotherapeutics in 2019 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 52 increasing their positions, 38 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
0% more ownership
Funds ownership: 4.23% → 4.23% (+0%)
1% less funds holding
Funds holding: 121 → 120 (-1)
6% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 16
Holders
120
Holding in Top 10
4
Calls
$7.58M
Puts
$2.16M
Top Buyers
| 1 | +$45.5M | |
| 2 | +$34.6M | |
| 3 | +$26.7M | |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$21.9M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$11.6M |
Top Sellers
| 1 | -$57.2M | |
| 2 | -$21.8M | |
| 3 | -$19.2M | |
| 4 |
BM
Bridger Management
New York
|
-$18.1M |
| 5 |
HCM
Highline Capital Management
New York
|
-$9.59M |